FA 12:2;O (BioDeep_00000628879)
Secondary id: BioDeep_00000006808, BioDeep_00000011116, BioDeep_00001869566, BioDeep_00001872479
代谢物信息卡片
化学式: C12H20O3 (212.14123700000002)
中文名称: (+/-)-茉莉酸甲酯, (+/-)-葫芦酸, 西葫芦酸, 11-十二烯酸
谱图信息:
最多检出来源 Macaca mulatta(otcml) 17.07%
分子结构信息
SMILES: C(/C=C(\C)/CC/C=C(\C)/CCCO)(=O)O
InChI: InChI=1S/C12H20O3/c1-2-3-5-8-11(13)9-6-4-7-10-12(14)15/h2H,1,3-10H2,(H,14,15)
描述信息
同义名列表
25 个代谢物同义名
[(1S,2S)-3-oxo-2-pentylcyclopentyl]acetic acid; (+)-9,10-dihydrojasmonic acid; FA 12:2;O; [(1R,2R)-3-oxo-2-pentylcyclopentyl]acetic acid; (-)-9,10-dihydrojasmonic acid; (+/-)-Dihydrojasmonic Acid; {(1R,2S,3S)-3-hydroxy-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid; 3ALPHA-HYDROXY-2BETA-(2Z-PENTENYL)-CYCLOPENTANE-1BETA-ACETIC ACID; (+/-)-3,4-METHYLENEDIOXYETHYLAMPHETAMINE; (3R,6S,7S)-cucurbic acid; (+)-cucurbic acid; (1R,2S)-3-oxo-2-pentyl-cyclopentaneacetic acid; (-)-7-epi--9,10-dihydrojasmonic acid; (1S,2R)-3-oxo-2-pentyl-cyclopentaneacetic acid; (+)-7-epi--9,10-dihydrojasmonic acid; 7-Oxo-11-dodecenoic acid; 12-oxo-9(Z)-dodecenoic acid; 12-oxo-9Z-dodecenoic acid; 9Z-traumatiin; 12-oxo-10Z-dodecenoic acid; 6S-hydroxy-2E,4E-dodecadienoic acid; Lycocasuarinen acid B; 8-Hydroxy-4,8-dimethyl-4E,9-decadienoic acid; 12-hydroxy-3Z,6Z-dodecadienoic acid; 10-Hydroxy-3,7-dimethyl-2E,6E-decadienoic acid
数据库引用编号
48 个数据库交叉引用编号
- ChEBI: CHEBI:18436
- ChEBI: CHEBI:18473
- ChEBI: CHEBI:18446
- ChEBI: CHEBI:180007
- ChEBI: CHEBI:180008
- ChEBI: CHEBI:176968
- ChEBI: CHEBI:19143
- ChEBI: CHEBI:137712
- ChEBI: CHEBI:168951
- ChEBI: CHEBI:169476
- ChEBI: CHEBI:180010
- KEGG: C08482
- KEGG: C16311
- PubChem: 40469793
- PubChem: 644120
- PubChem: 5281159
- PubChem: 9920768
- PubChem: 16061083
- PubChem: 4374065
- PubChem: 9548789
- PubChem: 5312890
- PubChem: 44256500
- PubChem: 5312748
- PubChem: 12454423
- ChEMBL: CHEMBL2272539
- LipidMAPS: LMFA02020205
- LipidMAPS: LMFA02020204
- LipidMAPS: LMFA02020013
- LipidMAPS: LMFA02020006
- LipidMAPS: LMFA02020005
- LipidMAPS: LMFA01060182
- LipidMAPS: LMFA01060167
- LipidMAPS: LMFA01060094
- LipidMAPS: LMFA01050595
- LipidMAPS: LMFA01050373
- LipidMAPS: LMFA01050171
- LipidMAPS: LMFA01030787
- CAS: 76968-33-7
- CAS: 98674-52-3
- CAS: 131488-83-0
- CAS: 58240-50-9
- CAS: 54921-60-7
- CAS: 60485-39-4
- PubChem: 10675
- KNApSAcK: C00001305
- NIKKAJI: J40.306G
- PubChem: 47205619
- NIKKAJI: J670.143D
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
23 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(23)
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(E)-2-hexenol + NADP+ ⟶ (E)-2-hexenal + H+ + NADPH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (3Z)-hexenal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (3Z)-hexenal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (3Z)-hexenal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (3Z)-hexenal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (3Z)-hexenal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (3Z)-hexenal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (3Z)-hexenal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
O2 + linoleate ⟶ (13S)-HPODE
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
O2 + linoleate ⟶ (13S)-HPODE
- superpathway of lipoxygenase:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (Z)-3-hexanal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (Z)-3-hexanal + H+ + NADH
- traumatin and (Z)-3-hexen-1-yl acetate biosynthesis:
(3Z)-hex-3-en-1-ol + NAD+ ⟶ (3Z)-hexenal + H+ + NADH
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
2 个相关的物种来源信息
- 5507 - Fusarium oxysporum: 10.1016/S0031-9422(98)00596-2
- 45133 - Lasiodiplodia theobromae: 10.1016/S0031-9422(00)82345-6
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- D W Barnes. Growth characteristics of A431 human epidermoid carcinoma cells in serum-free medium: inhibition by epidermal growth factor.
Advances in experimental medicine and biology.
1984; 172(?):49-66. doi:
10.1007/978-1-4615-9376-8_4
. [PMID: 6610292] - M F Lokhandwala, J P Buckley, B S Jandhyala. Studies on the mechanism of the cardiovascualr effects of methyldopa.
European journal of pharmacology.
1976 May; 37(1):79-89. doi:
10.1016/0014-2999(76)90010-8
. [PMID: 6292] - E Z Rabin, V Weinberger. The isolation, purification, and properties of a ribonuclease from normal human urine.
Biochemical medicine.
1975 Sep; 14(1):1-11. doi:
10.1016/0006-2944(75)90014-9
. [PMID: 2164]